OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer	285
Obesity and cancer	154
The functions and modifications of tRNA-derived small RNAs in cancer biology	130
Clonal tracking in cancer and metastasis	123
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities	97
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective	96
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms	85
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression	77
Regulation of dormancy during tumor dissemination: the role of the ECM	61
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions	60
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor	59
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?	58
CAR T-cell therapy to treat multiple myeloma: current state and future directions	56
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer	55
Targeting lipid metabolism in cancer: neuroblastoma	54
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives	52
p73 isoforms meet evolution of metastasis	46
Cell-cell interactions mediating primary and metastatic breast cancer dormancy	45
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond	43
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review	43
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?	41
Biography—Mathieu Boissan, Pharm.D., Ph.D	38
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer	37
Preface	37
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance	35

Biographies	33
Neuropeptide Y in cancer—biological functions and potential clinical implications	33
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications	32
The role of cancer cell bioenergetics in dormancy and drug resistance	32
Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis	32
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance	31